TrialAlzheimer's research & therapy2016

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease.

Jeffrey L Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.